UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The American heart journal, ISSN 0002-8703, 2016, Volume 182, pp. 89 - 96
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Simvastatin - adverse effects | Ezetimibe - adverse effects | Simvastatin - administration & dosage | Humans | Middle Aged | Male | Treatment Outcome | Ezetimibe - administration & dosage | Drug Monitoring - methods | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Dose-Response Relationship, Drug | Drug Synergism | Drug Therapy, Combination - methods | Anticholesteremic Agents - administration & dosage | Acute Coronary Syndrome - diagnosis | Cholesterol, LDL - blood | Drug Therapy, Combination - statistics & numerical data | Female | Aged | Clinical trials | Coronary heart disease | Simvastatin | Analysis | Cardiovascular disease | Health risk assessment | Low density lipoprotein | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
The American heart journal, ISSN 0002-8703, 2014, Volume 168, Issue 2, pp. 205 - 212.e1
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Simvastatin - therapeutic use | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Ezetimibe | Cholesterol, LDL - drug effects | Male | Azetidines - pharmacology | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Anticholesteremic Agents - pharmacology | Medical research | Low density lipoproteins | Simvastatin | Cardiac patients | Medicine, Experimental | Coronary heart disease | Antilipemic agents | Heart attacks | Acute coronary syndromes | Drug therapy | Cholesterol | Statins | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2009, Volume 103, Issue 3, pp. 369 - 374
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hypercholesterolemia - blood | Humans | Middle Aged | Ezetimibe | Male | Hypercholesterolemia - drug therapy | Randomized Controlled Trials as Topic | Azetidines - administration & dosage | Anticholesteremic Agents - administration & dosage | Cholesterol, LDL - blood | Female | C-Reactive Protein - analysis | Drug Therapy, Combination | Hypercholesterolemia | C-reactive protein | Low density lipoproteins | Clinical trials | Diabetes | Coronary heart disease | Trans fatty acids | Statins | Cholesterol | Cardiovascular agents | Cardiovascular disease | Cardiology | Drug therapy | Low density lipoprotein | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2011, Volume 108, Issue 4, pp. 523 - 530
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Metabolic diseases | Medical sciences | Disorders of blood lipids. Hyperlipoproteinemia | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Double-Blind Method | Pyrimidines - administration & dosage | Humans | Middle Aged | Ezetimibe | Rosuvastatin Calcium | Cholesterol, LDL - drug effects | Male | Treatment Outcome | Fluorobenzenes - administration & dosage | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Anticholesteremic Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Female | Aged | Drug Therapy, Combination | Fluorobenzenes - therapeutic use | Sulfonamides - administration & dosage | Cholesterol | Cardiovascular disease | Drug therapy | Cardiology | Low density lipoprotein | Statins | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2008, Volume 51, Issue 16, pp. 1564 - 1572
Cardiovascular | Internal Medicine | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Simvastatin - therapeutic use | Simvastatin - adverse effects | Humans | Middle Aged | Ezetimibe | Male | Niacin - administration & dosage | Niacin - therapeutic use | Lipids - blood | Niacin - adverse effects | Adult | Female | Hyperlipoproteinemia Type II - drug therapy | Drug Therapy, Combination | Hypolipidemic Agents - adverse effects | Cholesterol, HDL - drug effects | Simvastatin - administration & dosage | Azetidines - adverse effects | Cholesterol, LDL - drug effects | Apolipoproteins - drug effects | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Adolescent | Hypolipidemic Agents - administration & dosage | Hypolipidemic Agents - therapeutic use | Delayed-Action Preparations | Care and treatment | Drug therapy, Combination | Cardiology | Hyperlipidemia | Niacin | Confidence intervals | Lipoproteins | Mortality | Vitamin B | Cardiovascular disease | Lipids | Gallbladder | Triglycerides | Diabetes | Drug dosages | Patients | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2008, Volume 102, Issue 11, pp. 1495 - 1501
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Metabolic diseases | Medical sciences | Coronary heart disease | Disorders of blood lipids. Hyperlipoproteinemia | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Ezetimibe | Male | Heptanoic Acids - adverse effects | Hypercholesterolemia - drug therapy | Coronary Artery Disease - physiopathology | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Pyrroles - adverse effects | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Coronary Artery Disease - etiology | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Azetidines - adverse effects | Cholesterol, LDL - drug effects | Treatment Outcome | Anticholesteremic Agents - adverse effects | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Coronary Artery Disease - diagnosis | Anticholesteremic Agents - administration & dosage | Hypercholesterolemia - complications | Hypercholesterolemia - physiopathology | Medical colleges | Hypercholesterolemia | Low density lipoproteins | Atherosclerosis | Triglycerides | Comparative analysis | Risk factors | Trans fatty acids | Cholesterol | Antilipemic agents | Drugs | Medical research | Cardiovascular disease | Pharmacology | Drug therapy | Cardiology | Low density lipoprotein | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 4, pp. 353 - 361
Cardiovascular | Internal Medicine | simvastatin | total events | ezetimibe | low-density lipoprotein cholesterol | Medical colleges | Cardiology | Coronary heart disease | Low density lipoproteins | Cardiac patients | Hypertension | Heart attacks | Sensitivity analysis | Cardiovascular disease | Lipids | Cholesterol | Confidence intervals | Variables | Body mass index | Survival analysis | Coronary vessels | Diabetes | Acute coronary syndromes | Statins
Journal Article
American journal of kidney diseases, ISSN 0272-6386, 2011, Volume 57, Issue 6, pp. 963 - 965
Nephrology | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Kidneys | Urinary system involvement in other diseases. Miscellaneous | Nephropathies. Renovascular diseases. Renal failure | Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Hypolipidemic Agents - adverse effects | Dyslipidemias - drug therapy | Hypophosphatemia - blood | Drug Administration Schedule | Dyslipidemias - complications | Humans | Treatment Outcome | Indoles - administration & dosage | Dose-Response Relationship, Drug | Niacin - administration & dosage | Dyslipidemias - blood | Indoles - adverse effects | Kidney Failure, Chronic - blood | Lipids - blood | Hypolipidemic Agents - administration & dosage | Kidney Failure, Chronic - complications | Niacin - adverse effects | Hypophosphatemia - chemically induced | Drug Therapy, Combination | Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2010, Volume 105, Issue 5, pp. 656 - 663
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Hyperlipidemias - blood | Age Factors | Double-Blind Method | Humans | Hyperlipidemias - drug therapy | Middle Aged | Ezetimibe | Coronary Disease - etiology | Male | Treatment Outcome | Dose-Response Relationship, Drug | Atorvastatin Calcium | Coronary Disease - prevention & control | Azetidines - administration & dosage | Pyrroles - administration & dosage | Anticholesteremic Agents - administration & dosage | Triglycerides - blood | Heptanoic Acids - administration & dosage | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Hyperlipidemias - complications | Apolipoprotein A-I - blood | Cholesterol | Antilipemic agents | Studies | Older people | Cardiovascular disease | Lipids | Drug therapy | Low density lipoprotein | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2010, Volume 106, Issue 9, pp. 1255 - 1263
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Metabolic diseases | Medical sciences | Coronary heart disease | Disorders of blood lipids. Hyperlipoproteinemia | Simvastatin - therapeutic use | Heptanoic Acids - therapeutic use | Humans | Ezetimibe | Male | Hypercholesterolemia - drug therapy | Dose-Response Relationship, Drug | Pyrroles - administration & dosage | Lipids - blood | Heptanoic Acids - administration & dosage | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Double-Blind Method | Simvastatin - administration & dosage | Risk Factors | Logistic Models | Treatment Outcome | Biomarkers - blood | Atorvastatin Calcium | Coronary Disease - prevention & control | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Anticholesteremic Agents - administration & dosage | Aged | Cholesterol | Antilipemic agents | Drugs | Older people | Mortality | Cardiovascular disease | Cardiology | Low density lipoprotein | Statins | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2011, Volume 108, Issue 1, pp. 40 - 46
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Metabolic diseases | Medical sciences | Disorders of blood lipids. Hyperlipoproteinemia | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hypertriglyceridemia - drug therapy | Reproducibility of Results | Magnetic Resonance Spectroscopy - methods | Prognosis | Simvastatin - administration & dosage | Humans | Fenofibrate - administration & dosage | Apolipoproteins B - blood | Hypertriglyceridemia - blood | Hypolipidemic Agents - administration & dosage | Triglycerides - blood | Immunoassay - methods | Cholesterol, LDL - blood | Drug Therapy, Combination | Clinical trials | Immunoassay | Cardiology | Low density lipoprotein | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2009, Volume 103, Issue 12, pp. 1694 - 1702
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Miscellaneous | Other metabolic disorders | Biological and medical sciences | Metabolic diseases | Medical sciences | Disorders of blood lipids. Hyperlipoproteinemia | Simvastatin - therapeutic use | Follow-Up Studies | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Ezetimibe | Male | Hypercholesterolemia - drug therapy | Metabolic Syndrome - drug therapy | Dose-Response Relationship, Drug | Young Adult | Metabolic Syndrome - blood | Pyrroles - administration & dosage | Lipids - blood | Heptanoic Acids - administration & dosage | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Hypercholesterolemia - blood | Double-Blind Method | Simvastatin - administration & dosage | Treatment Outcome | Metabolic Syndrome - complications | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Anticholesteremic Agents - administration & dosage | Adolescent | Hypercholesterolemia - complications | Aged | Cholesterol | Antilipemic agents | Index Medicus | Abridged Index Medicus
Journal Article